
Full text loading...
Glycogen synthase kinase 3-beta (GSK3-β) is a protein that is linked to the formation of amyloid-beta (Aβ) plaques and neurofibrillary tangles, both of which are characteristic of Alzheimer's disease. The enzyme's hyperactivity phosphorylates tau proteins, forming neurofibrillary tangles that impair material transport between axons and dendrites and disrupt neuronal function. GSK3-β impacts amyloid precursor protein production, causing Aβ accumulation and neurodegeneration.
This study aimed to investigate the inhibitory mechanism of natural compounds from Bryophyllum pinnatum against GSK3-β.
Computational approach, extra precision glide docking, and the Maestro molecular interface of Schrodinger suites were utilized to determine the binding free energy of the compounds against the prepared GSK3-β. The compounds' ADME parameters and Lipinski's rule of five were also evaluated. Using AutoQSAR, predictive models were constructed for both protein targets.
Three hit compounds (kaempferol, quercetin, and 5,7,4'-trihydroxy-3,8-dimethoxyflavone) were found in this study. These compounds met the recommended range for the specified ADME parameters and passed the rule of five. Additionally, the hit compounds' predicted pIC50 values were promising.
Our study suggests that the investigated compounds can be used to design GSK3-β inhibitors.